Monthly Archives: April 2014

Recent article on the current sales of Gileads Hepatitis C drug Sovaldi (Sofusbuvir)

This was published just yesterday: Gilead Profit Triples, Hepatitis C Drug Revenue Reaches $2.3B http://www.foxbusiness.com/industries/2014/04/22/gilead-profit-triples-hepatitis-c-drug-revenue-reaches-23b/ Admiration to Henry Waxman (House of representatives) asking Gilead to explain the pricing of the drug! Advertisements

Call with Drug Bio Advisor Rachel Kiddell-Monroe

Yesterday, April 10th, we had an inspiring and motivating call with Rachel Kiddell-Monroe. She has agreed to be our “Drug Bio Advisor”, saying she thinks the project is extremely important for UAEM’s advocacy work! She said that finding information for the drug bios is challenging and that a bit of detective work will be required […]